共 174 条
[1]
Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29
[2]
Miller KD(2019)TCGA molecular groups of endometrial cancer: Pooled data about prognosis Gynecol Oncol 155 374-383
[3]
Jemal A(2021)ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Int J Gynecol Cancer 31 12-39
[4]
Raffone A(2013)Integrated genomic characterization of endometrial carcinoma Nature 497 67-73
[5]
Travaglino A(2015)Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative Mod Pathol 28 836-844
[6]
Mascolo M(2020)Molecular subtypes of clear cell carcinoma of the endometrium: opportunities for prognostic and predictive stratification Gynecol Oncol 158 3-11
[7]
Carbone L(2020)Molecularly classified uterine FIGO Grade 3 endometrioid carcinomas show distinctive clinical outcomes but overlapping morphologic features Am J Surg Pathol 45 421-429
[8]
Guida M(2020)Endometrial carcinomas with a "Serous" component in young women are enriched for dna mismatch repair deficiency, lynch syndrome, and POLE exonuclease domain mutations Am J Surg Pathol 44 641-648
[9]
Insabato L(2018)Molecular classification of Grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups Am J Surg Pathol 42 561-568
[10]
Zullo F(2017)The genetic landscape of endometrial clear cell carcinomas J Pathol 243 230-241